Quick Answer
International Stem Cell CORP reported Total Revenue of $9.10 million for the year ending 2025.
- International Stem Cell CORP showed an increase of +0.2% in Total Revenue from 2024 to 2025.
- This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $1.29 million | Q2 2013: $1.46 million | Q3 2013: $1.67 million | Q1 2014: $1.65 million | Q2 2014: $1.59 million | Q3 2014: $1.96 million | Q1 2015: $1.62 million | Q2 2015: $1.82 million | Q3 2015: $2.14 million | Q1 2016: $1.62 million | Q2 2016: $1.92 million | Q3 2016: $1.94 million | Q1 2017: $2.01 million | Q2 2017: $1.76 million | Q2 2017: $1.76 million | Q3 2017: $1.85 million | Q3 2017: $1.85 million | Q1 2018: $2.63 million | Q1 2018: $2.63 million | Q2 2018: $3.04 million | Q3 2018: $3.20 million | Q1 2019: $2.22 million | Q2 2019: $2.32 million | Q3 2019: $2.10 million | Q1 2020: $2.36 million | Q2 2020: $1.81 million | Q3 2020: $1.48 million | Q1 2021: $1.66 million | Q2 2021: $1.83 million | Q3 2021: $1.84 million | Q1 2022: $2.02 million | Q2 2022: $2.03 million | Q3 2022: $1.70 million | Q1 2023: $2.09 million | Q2 2023: $1.84 million | Q3 2023: $1.97 million | Q1 2024: $2.13 million | Q2 2024: $2.33 million | Q3 2024: $2.18 million | Q1 2025: $2.13 million | Q2 2025: $2.45 million | Q3 2025: $2.37 million.
- Over the full 17 years of available data (2010 to 2025), International Stem Cell CORP's Total Revenue has grown by 480.4%.
- Historical annual values: Fiscal year 2025: $9.10 million | Fiscal year 2024: $9.09 million | Fiscal year 2023: $7.79 million | Fiscal year 2022: $8.18 million | Fiscal year 2021: $7.18 million | Fiscal year 2020: $7.13 million | Fiscal year 2019: $9.47 million | Fiscal year 2018: $11.09 million | Fiscal year 2017: $7.46 million | Fiscal year 2017: $7.46 million | Fiscal year 2016: $7.17 million | Fiscal year 2015: $7.55 million | Fiscal year 2014: $7.02 million | Fiscal year 2013: $6.15 million | Fiscal year 2012: $4.57 million | Fiscal year 2011: $4.53 million | Fiscal year 2010: $1.57 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: